Vetter Provides Greater Flexibility in Secondary Packaging Through Collaborative Work

The CDMO increasingly relies on close interaction of humans and machines.
+ Successful implementation of collaborative dual-arm robot YuMi
+ Innovative response to rising customer demands for greater flexibility
+ Acquisition of more robots planned


Ravensburg: Vetter's core competencies include the manufacturing of safe, user-friendly, complex packaging systems such as the assembly of pens, autoinjectors and safety devices. Thanks to the many years of experience and expert knowledge of its employees, the contract development and manufacturing organization (CDMO) is able to meet the various requirements demanded of a drug product by regulatory authorities, customers and patients alike. In order to ensure customers' high quality standards, while at the same time offering a high degree of flexibility, in the future the pharmaceutical service provider will increasingly focus on collaborative work. Following a successful pilot project which included the use of a dual-arm robot in secondary packaging, the company is now planning the purchase of additional robots. 

While large industrial robots work in restricted areas where humans are not permitted to enter during operation, collaborative robots provide close cooperation between humans and machines. In fact, at this year's HANOVER TRADE FAIR, collaborative work was featured as one of the central topics. At Vetter, the collaborative dual-arm robot YuMi (You and Me) has been supporting automated secondary packaging processes since 2018. By inserting finished drug products and components into folding boxes, it performs an important task with a high degree of continuity and precision. Employees supply its work station with the required material and define its specific sequence of moves.

The acquisition of collaborative robots enables Vetter to meet the increasing demand for greater flexibility of its customers worldwide, and is playing an ever-greater role due to the growing diversity in packaging solutions and the trend towards smaller batches. "Fully automated systems allow fast throughput times and high quantities, but they lack flexibility due to long set-up times. This is exactly where our collaborative robot YuMi can make full use of its strengths," says Bernd Stauss, Senior Vice President Production and Engineering. Its high level of flexibility is based on a simple operating concept and excellent user-friendliness. These two qualities enable a wide range of deployment options and fast adaptation to changing product and packaging requirements.   

With the first collaborative robot now having been successfully deployed in a pilot project lasting more than a year, the company will be acquiring two more models. The first model will be used to assemble a prefilled syringe barrel with plunger rod and finger flange. After its successful implementation in secondary packaging, the second model will be used for what is known as speed-bin-picking in aseptic production where prefilled syringes are placed into trays after terminal sterilization.

Vetter provides greater flexibility in secondary packaging through colla...

Image via Vetter


Contact 

Vetter Pharma International GmbH 
Markus Kirchner 
Corporate Spokesperson / Media Relations 
Eywiesenstrasse 5 
88212 Ravensburg 
Germany 
Phone: +49 (0)751-3700-3729 
E-mail: PRnews@vetter-pharma.com 

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Vetter 

Headquartered in Ravensburg, Germany, Vetter is a global leading contract development and manufacturing organization (CDMO) with production facilities in Germany and the United States. Currently employing 4,600 individuals worldwide, the company has long-term experience in supporting biotechnology and pharmaceutical customers both large and small. Vetter services range from early stage development support including clinical manufacturing, to commercial supply and numerous packaging solutions for vials, syringes and cartridges. As a leading solution provider, Vetter appreciates its responsibility to support the needs of its customers by developing devices that contribute to increased patient safety, convenience, and enhanced compliance. Great importance is also given to social responsibility including environmental protection and sustainability.